APPLIED GENETIC TECHNOLOGIES (AGTC) Earnings History & Surprises

NASDAQ:AGTC • US03820J1007

Current stock price

0.3936 USD
+0 (+1.23%)
At close:
0.3936 USD
0 (0%)
After Hours:

AGTC Earnings overview

Past quarterly earnings results for APPLIED GENETIC TECHNOLOGIES (AGTC), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Earnings Snapshot

Next Earnings Date

Upcoming
Release Date
Feb 13, 2023
Period
Q2 / 2023
EPS Estimate
-$0.19
Revenue Estimate

Last Reported

Most Recent
Release Date
Nov 21, 2022
Period
Q1 / 2023
EPS Reported
-$0.28
EPS Surprise
-37.25%
Revenue Surprise
%

Beat Rate

Last 8 Quarters
0%
EPS and Revenue beats vs estimates

Quarterly Earnings Historical Results

EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.

QuarterEPSEPS EstEPS SurpriseEPS Q2QRevenueRevenue EstRevenue SurpriseRevenue Q2Q
Q1 2023 -0.28 -0.20 -37.25% 30.00% - -
Q4 2022 -0.36 -0.31 -14.78% -28.57% 325K - -35.00%
Q3 2022 -0.33 -0.29 -15.55% 17.50% - -
Q2 2022 -0.45 -0.34 -30.86% 25.00% - -
Q1 2022 -0.40 -0.44 8.19% 33.33% - -
Q4 2021 -0.28 -0.39 28.23% 50.00% 500K - -
Q3 2021 -0.40 -0.36 -12.04% 20.00% 84.997K -100.00% -
Q2 2021 -0.60 -0.41 -47.06% -27.66% - -100.00%
Q1 2021 -0.60 -0.42 -42.60% 6.25% - -
Q4 2020 -0.56 -0.60 6.68% - - -
Q3 2020 -0.50 -0.54 7.80% - 102K -100.00% -
Q2 2020 -0.47 -0.49 4.29% - 2.45M - -
Q1 2020 -0.64 -0.56 -14.08% - 40.8K -100.00% -

Notes

  • EPS and Revenue values are non-GAAP when available, otherwise GAAP.
  • Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
  • Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
  • Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

AGTC EPS Q2Q GrowthAGTC EPS Q2Q GrowthEPS Q2Q Growth Q1/21 Q2/21 Q3/21 Q4/21 Q1/22 Q2/22 Q3/22 Q4/22 Q1/23 Q2/23 Q3/23 Q4/23 Q1/24 Q2/24 Q3/24 Q4/24 Q1/25 Q2/25 0 -100 -200

Revenue Historical Q2Q growth and Acceleration

AGTC Revenue Q2Q GrowthAGTC Revenue Q2Q GrowthRevenue Q2Q Growth Q2/21 Q4/22 -20 -40 -60 -80

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)
0
Average EPS beat (4)
-24.61%
Max EPS beat (4)
-14.78%
Min EPS beat (4)
-37.25%

Revenue beat statistics

Revenue beat (4)
N/A
Average Revenue beat (4)
N/A
Max Revenue beat (4)
N/A
Min Revenue beat (4)
N/A

Analysis

In the last 4 quarters, AGTC has not beaten EPS estimates in any release
In the last 4 quarters, AGTC reported -24.6% below the EPS estimates on average.
AGTC Overview AGTC Technical Analysis Report AGTC Fundamental Analysis Report AGTC Forecast & Price Target
→ Find peers who consistently beat earnings by at least 10% in the last 4 quarters

APPLIED GENETIC TECHNOLOGIES / AGTC Earnings FAQ

What is the most recent earnings date for AGTC stock?

APPLIED GENETIC TECHNOLOGIES (AGTC) last reported earnings on 11/21/2022.

Can you provide information on whether APPLIED GENETIC TECHNOLOGIES beat earnings estimates in the last quarter?

APPLIED GENETIC TECHNOLOGIES (AGTC) missed EPS estimates and missed revenue estimates in the most recent quarter.

What percentage of the time does AGTC stock beat earnings estimates?

In the last 4 quarters, APPLIED GENETIC TECHNOLOGIES (AGTC) has beaten EPS estimates in 0 out of 4 releases.